Viemed Healthcare, Inc.
VMD
$9.65
$0.020.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.54% | 25.51% | 23.98% | 14.72% | 16.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.54% | 25.51% | 23.98% | 14.72% | 16.87% |
| Cost of Revenue | 26.06% | 30.63% | 29.35% | 19.26% | 24.33% |
| Gross Profit | 28.69% | 22.04% | 20.29% | 11.67% | 11.67% |
| SG&A Expenses | 21.27% | 15.73% | 17.20% | 11.43% | 17.28% |
| Depreciation & Amortization | 11.49% | 12.83% | 14.08% | -6.37% | -16.14% |
| Other Operating Expenses | 53.33% | 93.83% | 84.06% | 78.64% | -188.46% |
| Total Operating Expenses | 22.78% | 23.81% | 22.93% | 15.31% | 19.77% |
| Operating Income | 203.34% | 40.34% | 34.69% | 7.63% | -38.35% |
| Income Before Tax | 8.98% | 26.99% | -6.62% | 121.07% | 72.65% |
| Income Tax Expenses | 34.24% | 16.48% | -3.70% | 123.05% | 83.78% |
| Earnings from Continuing Operations | 0.11% | 31.46% | -7.81% | 120.04% | 69.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -54.12% | -63.89% | -222.22% | -933.33% | -- |
| Net Income | -1.64% | 30.65% | -9.41% | 115.05% | 63.76% |
| EBIT | 203.34% | 40.34% | 34.69% | 7.63% | -38.35% |
| EBITDA | 51.11% | 29.54% | 25.26% | 8.59% | -7.27% |
| EPS Basic | 0.90% | 34.09% | -8.92% | 111.38% | 60.87% |
| Normalized Basic EPS | 247.72% | 40.69% | 27.11% | 48.01% | -50.13% |
| EPS Diluted | 0.00% | 29.77% | -9.82% | 111.38% | 50.00% |
| Normalized Diluted EPS | 247.59% | 41.61% | 27.28% | 48.73% | -50.27% |
| Average Basic Shares Outstanding | -2.53% | -2.59% | -0.60% | 1.78% | 1.83% |
| Average Diluted Shares Outstanding | -2.73% | -3.29% | -0.70% | 1.31% | 2.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |